NCT05382559 2026-03-02A Study of ASP3082 in Adults With Advanced Solid TumorsAstellas Pharma IncPhase 1 Recruiting681 enrolled
NCT03504397 2026-02-13SpotlightAstellas Pharma IncPhase 3 Active not recruiting565 enrolled 63 charts 1 FDA
NCT03653507 2026-02-06GLOWAstellas Pharma IncPhase 3 Active not recruiting507 enrolled 65 charts 1 FDA
NCT07366528 2026-01-26Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric CancerRuijin HospitalPhase 3 Recruiting387 enrolled